Chicago Partners Investment Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Chicago Partners Investment Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	+1,882	New	+$204K	﹤0.01%	1375
2024 Q4	–	Sell	-2,416	Closed	-$210K	–	871
2024 Q3	$210K	Sell	2,416 -14	-0.6%	-$1.2K	0.01%	747
2024 Q2	$210K	Buy	+2,430	New	+$193K	0.01%	703
2024 Q1	–	Sell	-2,866	Closed	-$219K	–	750
2023 Q4	$219K	Sell	2,866 -632	-18%	-$45.2K	0.01%	631
2023 Q3	$244K	Buy	3,498 +4	+0.1%	+$307	0.01%	557
2023 Q2	$271K	Sell	3,494 -1,145	-25%	-$87.4K	0.01%	554
2023 Q1	$366K	Buy	+4,639	New	+$358K	0.02%	464

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

Chicago Partners Investment Group's PJP Position: Q2 2026 in Review

Chicago Partners Investment Group opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q2 2026: 1,882 shares worth $226K. The stake represents ﹤0.01% of the portfolio and ranks #1375 among its holdings. This is a return to the name: Chicago Partners Investment Group previously reported a position in PJP as recently as Q3 2024.

Chicago Partners Investment Group first reported a position in PJP in Q1 2023 and has held it in 7 quarters since. The position peaked at $366K in Q1 2023. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

Chicago Partners Investment Group held 1,882 shares of Invesco Pharmaceuticals ETF worth $226K as of Q2 2026.
Invesco Pharmaceuticals ETF was a new Chicago Partners Investment Group position in Q2 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #1375 holding.
Chicago Partners Investment Group first reported a position in Invesco Pharmaceuticals ETF in Q1 2023 and has held it in 7 quarters since.
Chicago Partners Investment Group's Invesco Pharmaceuticals ETF position peaked at $366K in Q1 2023.
117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.